Maps and legends: The quest for dissociated ligands of the glucocorticoid receptor

Aagaard, 2011, Molecular basis for gene-specific transactivation by nuclear receptors, Biochim Biophys Acta, 1812, 824, 10.1016/j.bbadis.2010.12.018

Abraham, 2006, Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1, J Exp Med, 203, 1883, 10.1084/jem.20060336

Auphan, 1995, Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis, Science, 270, 286, 10.1126/science.270.5234.286

Avenant, 2010, Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment, Biochemistry, 49, 972, 10.1021/bi901956s

Barnes, 1995, Anti-inflammatory mechanisms of glucocorticoids, Biochem Soc Trans, 23, 940, 10.1042/bst0230940

Barnes, 2006, Corticosteroids: the drugs to beat, Eur J Pharmacol, 533, 2, 10.1016/j.ejphar.2005.12.052

Baschant, 2011, Glucocorticoid therapy of arthritis depends on the dimerized glucocorticoid receptor in T cells, Proc Natl Acad Sci U S A, 108, 19317, 10.1073/pnas.1105857108

Beaulieu, 2011, Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis, Nat Rev Rheumatol, 7, 340, 10.1038/nrrheum.2011.59

Beaulieu, 2010, Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis, Arthritis Rheum, 62, 2651, 10.1002/art.27566

Beausoleil, 2006, A probability-based approach for high-throughput protein phosphorylation analysis and site localization, Nat Biotechnol, 24, 1285, 10.1038/nbt1240

Beck, 2009, Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases, Endocr Rev, 30, 830, 10.1210/er.2009-0013

Belvisi, 2001, Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity, J Immunol, 166, 1975, 10.4049/jimmunol.166.3.1975

Bergmann, 2004, Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0, Am J Respir Cell Mol Biol, 30, 555, 10.1165/rcmb.2003-0295OC

Berlin, 2010, Recent advances in the development of novel glucocorticoid receptor modulators, Expert Opin Ther Pat, 20, 855, 10.1517/13543776.2010.493876

Bhandare, 2010, Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells, Am J Respir Cell Mol Biol, 42, 9, 10.1165/rcmb.2009-0239RC

Biddie, 2010, Genome-wide mechanisms of nuclear receptor action, Trends Endocrinol Metab, 21, 3, 10.1016/j.tem.2009.08.006

Biddie, 2011, Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding, Mol Cell, 43, 145, 10.1016/j.molcel.2011.06.016

Bilodeau, 2006, Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease, Genes Dev, 20, 2871, 10.1101/gad.1444606

Bladh, 2009, Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)-kappaB activity by glucocorticoids, Biochim Biophys Acta, 1793, 439, 10.1016/j.bbamcr.2008.11.013

Bledsoe, 2002, Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition, Cell, 110, 93, 10.1016/S0092-8674(02)00817-6

Boldizsar, 2010, Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells, Immunobiology, 215, 521, 10.1016/j.imbio.2009.10.003

Buckingham, 2006, Glucocorticoids: exemplars of multi-tasking, Br J Pharmacol, 147, S258, 10.1038/sj.bjp.0706456

Caldenhoven, 1995, Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids, Mol Endocrinol, 9, 401, 10.1210/me.9.4.401

Cato, 1996, Molecular mechanisms of anti-inflammatory action of glucocorticoids, Bioessays, 18, 371, 10.1002/bies.950180507

Chang, 2001, Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells, Am J Physiol Lung Cell Mol Physiol, 280, L107, 10.1152/ajplung.2001.280.1.L107

Chaudhary, 1996, Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells, J Biol Chem, 271, 16591, 10.1074/jbc.271.28.16591

Chen, 2008, Glucocorticoid receptor phosphorylation differentially affects target gene expression, Mol Endocrinol, 22, 1754, 10.1210/me.2007-0219

Chen, 2006, MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor, Mol Endocrinol, 20, 560, 10.1210/me.2005-0318

Chinenov, 2007, Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network, Mol Cell Endocrinol, 275, 30, 10.1016/j.mce.2007.04.014

Chinenov, 2008, GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression, Proc Natl Acad Sci U S A, 105, 20185, 10.1073/pnas.0810863105

Chivers, 2006, Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids, Mol Pharmacol, 70, 2084, 10.1124/mol.106.025841

Cho, 2009, A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GR, Mol Endocrinol, 23, 86, 10.1210/me.2008-0257

Chung, 2011, Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications, Biochim Biophys Acta, 1812, 581, 10.1016/j.bbadis.2011.02.003

Clark, 2007, Anti-inflammatory functions of glucocorticoid-induced genes, Mol Cell Endocrinol, 275, 79, 10.1016/j.mce.2007.04.013

Clarke, 2007, The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle, Cell Metab, 6, 376, 10.1016/j.cmet.2007.09.009

Cole, 1995, Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation, Genes Dev, 9, 1608, 10.1101/gad.9.13.1608

Conradie, 2011, MKP-1 knockout does not prevent glucocorticoid-induced bone disease in mice, Calcif Tissue Int, 89, 221, 10.1007/s00223-011-9509-x

Conradie, 2007, Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo, J Endocrinol, 195, 229, 10.1677/JOE-07-0217

Coutinho, 2011, The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights, Mol Cell Endocrinol, 335, 2, 10.1016/j.mce.2010.04.005

Dahlman-Wright, 1993, Protein–protein interactions between the DNA-binding domains of nuclear receptors: influence on DNA-binding, J Steroid Biochem Mol Biol, 45, 239, 10.1016/0960-0760(93)90338-W

Dahlman-Wright, 1992, Determinants of high-affinity DNA binding by the glucocorticoid receptor: evaluation of receptor domains outside the DNA-binding domain, Biochemistry, 31, 9040, 10.1021/bi00152a047

Dahlman-Wright, 1991, Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids, J Biol Chem, 266, 3107, 10.1016/S0021-9258(18)49960-7

Daub, 2008, Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle, Mol Cell, 31, 438, 10.1016/j.molcel.2008.07.007

De Bosscher, 2010, Targeting inflammation using selective glucocorticoid receptor modulators, Curr Opin Pharmacol, 10, 497, 10.1016/j.coph.2010.04.007

De Bosscher, 2005, A fully dissociated compound of plant origin for inflammatory gene repression, Proc Natl Acad Sci U S A, 102, 15827, 10.1073/pnas.0505554102

Dephoure, 2008, A quantitative atlas of mitotic phosphorylation, Proc Natl Acad Sci U S A, 105, 10762, 10.1073/pnas.0805139105

Dhawan, 2007, A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability, J Biol Chem, 282, 10146, 10.1074/jbc.M605925200

Dickmeis, 2011, Glucocorticoids and circadian clock control of cell proliferation: at the interface between three dynamic systems, Mol Cell Endocrinol, 331, 11, 10.1016/j.mce.2010.09.001

Diefenbacher, 2008, Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1, Mol Endocrinol, 22, 1767, 10.1210/me.2007-0574

Dostert, 2004, Negative glucocorticoid receptor response elements and their role in glucocorticoid action, Curr Pharm Des, 10, 2807, 10.2174/1381612043383601

Draper, 2005, 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action, J Endocrinol, 186, 251, 10.1677/joe.1.06019

Eberhardt, 2005, Dissociated glucocorticoids equipotently inhibit cytokine- and cAMP-induced matrix degrading proteases in rat mesangial cells, Biochem Pharmacol, 70, 433, 10.1016/j.bcp.2005.05.007

Essilfie-Quaye, 2011, Comparison of symbicort versus pulmicort on steroid pharmacodynamic markers in asthma patients, Respir Med, 105, 1784, 10.1016/j.rmed.2011.08.020

Fardet, 2011, Prevalence of long-term oral glucocorticoid prescriptions in UK over the past 20years, Rheumatology (Oxford), 50, 1982, 10.1093/rheumatology/ker017

Flammer, 2010, The type I interferon signaling pathway is a target for glucocorticoid inhibition, Mol Cell Biol, 30, 4564, 10.1128/MCB.00146-10

Flammer, 2011, Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms, Mol Endocrinol, 25, 1075, 10.1210/me.2011-0068

Frijters, 2010, Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor, BMC Genomics, 11, 359, 10.1186/1471-2164-11-359

Furst, 2007, MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium, FASEB J, 21, 74, 10.1096/fj.06-6752com

Galliher-Beckley, 2009, Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease, IUBMB Life, 61, 979, 10.1002/iub.245

Galliher-Beckley, 2008, Glycogen synthase kinase 3{beta}-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles, Mol Cell Biol, 28, 7309, 10.1128/MCB.00808-08

Geserick, 2005, The role of DNA response elements as allosteric modulators of steroid receptor function, Mol Cell Endocrinol, 236, 1, 10.1016/j.mce.2005.03.007

Gilson, 2007, Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy, Endocrinology, 148, 452, 10.1210/en.2006-0539

Glass, 2010, Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells, Nat Rev Immunol, 10, 365, 10.1038/nri2748

Gorter, 2010, Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis, Ann Rheum Dis, 69, 1010, 10.1136/ard.2009.127332

Gossye, 2009, Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts, Arthritis Rheum, 60, 3241, 10.1002/art.24963

Grad, 2007, The glucocorticoid responses are shaped by molecular chaperones, Mol Cell Endocrinol, 275, 2, 10.1016/j.mce.2007.05.018

Groeneweg, 2011, Rapid non-genomic effects of corticosteroids and their role in the central stress response, J Endocrinol, 209, 153, 10.1530/JOE-10-0472

Gronemeyer, 2009, Allosteric effects govern nuclear receptor action: DNA appears as a player, Sci Signal, 2, pe34, 10.1126/scisignal.273pe34

Haendler, B., & Cleve, A. in press. Recent developments in antiandrogens and selective androgen receptor modulators. Mol Cell Endocrinol.

Hakim, 2009, Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions, J Biol Chem, 284, 6048, 10.1074/jbc.C800212200

Han, 2009, Multi-modulation of nuclear receptor coactivators through posttranslational modifications, Trends Endocrinol Metab, 20, 8, 10.1016/j.tem.2008.10.001

Hargreaves, 2009, Control of inducible gene expression by signal-dependent transcriptional elongation, Cell, 138, 129, 10.1016/j.cell.2009.05.047

Heck, 1997, I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor, EMBO J, 16, 4698, 10.1093/emboj/16.15.4698

Heck, 1994, A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1, EMBO J, 13, 4087, 10.1002/j.1460-2075.1994.tb06726.x

Hench, 1964, 312

Hillier, 2007, Diamonds are forever: the cortisone legacy, J Endocrinol, 195, 1, 10.1677/JOE-07-0309

Hoes, 2010, Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis, Nat Rev Rheumatol, 6, 693, 10.1038/nrrheum.2010.179

Hofbauer, 2009, Minireview: live and let die: molecular effects of glucocorticoids on bone cells, Mol Endocrinol, 23, 1525, 10.1210/me.2009-0069

Horsch, 2007, Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation, Mol Endocrinol, 21, 2929, 10.1210/me.2007-0153

Hudson, 2008, Recent developments in the discovery of selective glucocorticoid receptor modulators (SGRMs), Curr Top Med Chem, 8, 750, 10.2174/156802608784535048

Ishmael, 2008, Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation, J Immunol, 180, 8342, 10.4049/jimmunol.180.12.8342

Ishmael, 2011, The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif, J Immunol, 186, 1189, 10.4049/jimmunol.1001794

Islam, 2008, Glucocorticoid/glucocorticoid receptor inhibition of surfactant protein-A (SP-A) gene expression in lung type II cells is mediated by repressive changes in histone modification at the SP-A promoter, Mol Endocrinol, 22, 585, 10.1210/me.2007-0412

Ismaili, 2005, Stabilization of the unliganded glucocorticoid receptor by TSG101, J Biol Chem, 280, 11120, 10.1074/jbc.M500059200

Ito, 2000, Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12, Mol Cell Biol, 20, 6891, 10.1128/MCB.20.18.6891-6903.2000

Janka-Junttila, 2006, The glucocorticoid RU24858 does not distinguish between transrepression and transactivation in primary human eosinophils, J Inflamm (Lond), 3, 10, 10.1186/1476-9255-3-10

Joanny, 2012, Anti-inflammatory effects of selective glucocorticoid receptor modulators (SGRMs) are partially dependent on upregulation of dual specificity phosphatase 1 (DUSP1), Br J Pharmacol, 65, 1124, 10.1111/j.1476-5381.2011.01574.x

John, 2008, Interaction of the glucocorticoid receptor with the chromatin landscape, Mol Cell, 29, 611, 10.1016/j.molcel.2008.02.010

John, 2011, Chromatin accessibility pre-determines glucocorticoid receptor binding patterns, Nat Genet, 43, 264, 10.1038/ng.759

Jones, 2009, Improving selective androgen receptor modulator discovery and preclinical evaluation, Curr Opin Drug Discov, 4, 981, 10.1517/17460440903206957

Kang, 2008, Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: role of dual specificity phosphatase 1, Am J Physiol Lung Cell Mol Physiol, 295, L186, 10.1152/ajplung.00352.2007

Kanis, 2007, Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis, Health Technol Assess, 11, iii, 10.3310/hta11070

Kelly, M., King, E., Rider, C., Gwozd, C., Holden, N., Eddleston, J., Zuraw, B., Leigh, R., O'Byrne, P., & Newton, R. (in press) Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide. Br J Pharmacol, doi: 10.1111/j.1476-5381.2011.01620.x.

King, 2009, Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK, J Biol Chem, 284, 26803, 10.1074/jbc.M109.028381

Kino, 2011, Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: implications for cardiometabolic diseases, Endocr Dev, 20, 116, 10.1159/000321232

Kirwan, 2007, Effects of glucocorticoids on radiological progression in rheumatoid arthritis, Cochrane Database Syst Rev, 10.1002/14651858.CD006356

Kleiman, 2007, Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice, Mol Cell Endocrinol, 275, 98, 10.1016/j.mce.2007.05.009

Kleiman, A., Hubner, S., Rodriguez Parkitna, J. M., Neumann, A., Hofer, S., Weigand, M. A., Bauer, M., Schmid, W., Schutz, G., Libert, C., Reichardt, H. M., & Tuckermann, J. P. (in press). Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J.

Lefstin, 1994, Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions, Genes Dev, 8, 2842, 10.1101/gad.8.23.2842

Leitman, 2010, Regulation of specific target genes and biological responses by estrogen receptor subtype agonists, Curr Opin Pharmacol, 10, 629, 10.1016/j.coph.2010.09.009

Li, 2011, Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids, Eur Respir J, 37, 933, 10.1183/09031936.00021110

Liden, 1997, A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation, J Biol Chem, 272, 21467, 10.1074/jbc.272.34.21467

Lopez, 2008, LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo, Endocrinology, 149, 2080, 10.1210/en.2007-1353

Luecke, 2005, The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression, Genes Dev, 19, 1116, 10.1101/gad.1297105

Ma, 2004, Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors, J Immunol, 172, 318, 10.4049/jimmunol.172.1.318

Malovannaya, 2011, Analysis of the human endogenous coregulator complexome, Cell, 145, 787, 10.1016/j.cell.2011.05.006

Martens, 2011, Genome-wide interplay of nuclear receptors with the epigenome, Biochim Biophys Acta, 1812, 818, 10.1016/j.bbadis.2010.10.005

McDonnell, 2010, The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer, Curr Opin Pharmacol, 10, 620, 10.1016/j.coph.2010.09.007

McEwan, 1997, Mechanism of gene expression by the glucocorticoid receptor: role of protein–protein interactions, Bioessays, 19, 153, 10.1002/bies.950190210

McKenna, 2009, Minireview: evolution of NURSA, the Nuclear Receptor Signaling Atlas, Mol Endocrinol, 23, 740, 10.1210/me.2009-0135

McMaster, 2008, Drug insight: selective agonists and antagonists of the glucocorticoid receptor, Nat Clin Pract Endocrinol Metab, 4, 91, 10.1038/ncpendmet0745

Meijsing, 2009, DNA binding site sequence directs glucocorticoid receptor structure and activity, Science, 324, 407, 10.1126/science.1164265

Miner, 2007, Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein–protein interaction profile, Proc Natl Acad Sci U S A, 104, 19244, 10.1073/pnas.0705517104

Miner, 2005, New and improved glucocorticoid receptor ligands, Expert Opin Investig Drugs, 14, 1527, 10.1517/13543784.14.12.1527

Mukaida, 1994, Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression, J Biol Chem, 269, 13289, 10.1016/S0021-9258(17)36831-X

Nader, 2010, Interactions of the circadian CLOCK system and the HPA axis, Trends Endocrinol Metab, 21, 277, 10.1016/j.tem.2009.12.011

Newton, 2000, Molecular mechanisms of glucocorticoid action: what is important?, Thorax, 55, 603, 10.1136/thorax.55.7.603

Newton, 2007, Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?, Mol Pharmacol, 72, 799, 10.1124/mol.107.038794

Newton, 2010, Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1, Biochem J, 427, 113, 10.1042/BJ20091038

Newton, 1998, Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA, J Biol Chem, 273, 32312, 10.1074/jbc.273.48.32312

Nie, 2005, Beta2-adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation, J Immunol, 175, 478, 10.4049/jimmunol.175.1.478

Nilsson, 2011, Estrogen receptors: therapies targeted to receptor subtypes, Clin Pharmacol Ther, 89, 44, 10.1038/clpt.2010.226

Nissen, 2000, The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain, Genes Dev, 14, 2314, 10.1101/gad.827900

Oakley, 2011, Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids, J Biol Chem, 286, 3177, 10.1074/jbc.R110.179325

Ogawa, 2005, Molecular determinants of crosstalk between nuclear receptors and toll-like receptors, Cell, 122, 707, 10.1016/j.cell.2005.06.029

O'Malley, 2008, Coactivators and corepressors: what's in a name?, Mol Endocrinol, 22, 2213, 10.1210/me.2008-0201

Qiu, 2011, Dynamic interaction of HDAC1 with a glucocorticoid receptor-regulated gene is modulated by the activity state of the promoter, J Biol Chem, 286, 7641, 10.1074/jbc.M110.185488

Quante, 2008, Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1, Am J Respir Cell Mol Biol, 39, 208, 10.1165/rcmb.2007-0014OC

Rao, 2011, Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes, Genome Res, 21, 1404, 10.1101/gr.118042.110

Rauch, 2011, An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation, FASEB J, 25, 1323, 10.1096/fj.10-173393

Rauch, 2010, Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor, Cell Metab, 11, 517, 10.1016/j.cmet.2010.05.005

Rauner, 2011, Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells, Endocrinology, 152, 103, 10.1210/en.2010-0456

Reddy, 2009, Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation, Genome Res, 19, 2163, 10.1101/gr.097022.109

Reichardt, 1998, DNA binding of the glucocorticoid receptor is not essential for survival, Cell, 93, 531, 10.1016/S0092-8674(00)81183-6

Reichardt, 2001, Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor, EMBO J, 20, 7168, 10.1093/emboj/20.24.7168

Reily, 2006, The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression, EMBO J, 25, 108, 10.1038/sj.emboj.7600919

Robertson, 2010, Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound A, J Biol Chem, 285, 8061, 10.1074/jbc.M109.087866

Rogatsky, 2002, Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts, Proc Natl Acad Sci U S A, 99, 16701, 10.1073/pnas.262671599

Rogatsky, 2003, Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor, Proc Natl Acad Sci U S A, 100, 13845, 10.1073/pnas.2336092100

Rogatsky, 2001, Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones, EMBO J, 20, 6071, 10.1093/emboj/20.21.6071

Ronacher, 2009, Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction, Mol Cell Endocrinol, 299, 219, 10.1016/j.mce.2008.10.008

Sahu, 2011, Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer, EMBO J, 30, 3962, 10.1038/emboj.2011.328

Santos, 2011, Negative regulation by nuclear receptors: a plethora of mechanisms, Trends Endocrinol Metab, 22, 87, 10.1016/j.tem.2010.11.004

Schacke, 2007, Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index, Mol Cell Endocrinol, 275, 109, 10.1016/j.mce.2007.05.014

Schacke, 2002, Mechanisms involved in the side effects of glucocorticoids, Pharmacol Ther, 96, 23, 10.1016/S0163-7258(02)00297-8

Schacke, 2005, Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index, Curr Opin Investig Drugs, 6, 503

Scheinman, 1995, Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids, Science, 270, 283, 10.1126/science.270.5234.283

Siersbaek, 2011, Extensive chromatin remodelling and establishment of transcription factor ‘hotspots’ during early adipogenesis, EMBO J, 30, 1459, 10.1038/emboj.2011.65

Simons, 2008, What goes on behind closed doors: physiological versus pharmacological steroid hormone actions, Bioessays, 30, 744, 10.1002/bies.20792

Smoak, 2006, Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling, Mol Cell Biol, 26, 9126, 10.1128/MCB.00679-06

So, 2009, Glucocorticoid regulation of the circadian clock modulates glucose homeostasis, Proc Natl Acad Sci U S A, 106, 17582, 10.1073/pnas.0909733106

So, 2007, Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor, PLoS Genet, 3, e94, 10.1371/journal.pgen.0030094

So, 2008, Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes, Proc Natl Acad Sci U S A, 105, 5745, 10.1073/pnas.0801551105

Staples, 2003, Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone, Immunology, 109, 527, 10.1046/j.1365-2567.2003.01679.x

Stellato, 2004, Post-transcriptional and nongenomic effects of glucocorticoids, Proc Am Thorac Soc, 1, 255, 10.1513/pats.200402-015MS

Surjit, 2011, Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor, Cell, 145, 224, 10.1016/j.cell.2011.03.027

Tanigawa, 2002, Cell type-dependent divergence of transactivation by glucocorticoid receptor ligand, Biol Pharm Bull, 25, 1619, 10.1248/bpb.25.1619

Taves, 2011, Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function, Am J Physiol Endocrinol Metab, 301, E11, 10.1152/ajpendo.00100.2011

Tsaprouni, 2007, Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation, Clin Exp Immunol, 150, 151, 10.1111/j.1365-2249.2007.03484.x

Tuckermann, 2007, Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy, J Clin Invest, 117, 1381, 10.1172/JCI28034

Tuckermann, 1999, The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin, J Cell Biol, 147, 1365, 10.1083/jcb.147.7.1365

van der Laan, 2008, Pharmacology of glucocorticoids: beyond receptors, Eur J Pharmacol, 585, 483, 10.1016/j.ejphar.2008.01.060

van Loo, 2010, Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis, Mol Endocrinol, 24, 310, 10.1210/me.2009-0236

van Raalte, 2009, Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?, Eur J Clin Invest, 39, 81, 10.1111/j.1365-2362.2008.02067.x

van Staa, 2000, Use of oral corticosteroids in the United Kingdom, QJM, 93, 105, 10.1093/qjmed/93.2.105

Vayssiere, 1997, Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo, Mol Endocrinol, 11, 1245, 10.1210/me.11.9.1245

Visser, 2010, Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6, Endocrinology, 151, 5279, 10.1210/en.2010-0368

Waddell, 2008, The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene, Am J Physiol Endocrinol Metab, 295, E785, 10.1152/ajpendo.00646.2007

Wang, 2004, Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes, Proc Natl Acad Sci U S A, 101, 15603, 10.1073/pnas.0407008101

Wang, 2008, The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia, Life Sci, 83, 671, 10.1016/j.lfs.2008.09.003

Webster, 1997, Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein, J Biol Chem, 272, 9287, 10.1074/jbc.272.14.9287

Weinstein, 2011, Clinical practice. Glucocorticoid-induced bone disease, N Engl J Med, 365, 62, 10.1056/NEJMcp1012926

Whitehouse, 2011, Anti-inflammatory glucocorticoid drugs: reflections after 60years, Inflammopharmacology, 19, 1, 10.1007/s10787-010-0056-2

Wiench, 2011, DNA methylation status predicts cell type-specific enhancer activity, EMBO J, 30, 3028, 10.1038/emboj.2011.210

Wu, 2005, Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival, J Biol Chem, 280, 4117, 10.1074/jbc.M411200200

Wust, 2009, Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis, PLoS One, 4, e8202, 10.1371/journal.pone.0008202

Yemelyanov, 2008, Novel steroid receptor phyto-modulator compound A inhibits growth and survival of prostate cancer cells, Cancer Res, 68, 4763, 10.1158/0008-5472.CAN-07-6104

York, 2010, Steroid receptor coactivator (SRC) family: masters of systems biology, J Biol Chem, 285, 38743, 10.1074/jbc.R110.193367

Yu, 2011, MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1, Cytokine, 56, 245, 10.1016/j.cyto.2011.06.006